Diagnostic value of tumor-educated platelet transcriptomics in cancer: a systematic review of technical considerations and diagnostic accuracy

Cancer remains a leading cause of morbidity and mortality worldwide, and the search for noninvasive markers for cancer screening and diagnosis, as well as for patient monitoring, is of utmost importance to better and earlier detect cancer. As the second most abundant cell type in the bloodstream, platelets interact bidirectionally with cancer cells, acquiring cancer-associated molecular alterations that modify their transcriptomic profile and give rise to so-called tumor-educated platelets (TEPs). As an easily accessible and abundant blood component, TEPs have emerged as a promising liquid biopsy source for cancer diagnostic biomarkers. This systematic review aimed to evaluate the clinical utility of the TEP transcriptome as a potential source of diagnostic biomarkers in solid and hematological neoplasias. It also identifies the major challenges and future perspectives for their clinical implementation. The review protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO: CRD42024486960).

Authors

Publication Details

Journal
Figshare
Published
2026-11-19
DOI
https://doi.org/10.6084/m9.figshare.35060429
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic value of tumor-educated platelet transcriptomics in cancer: a systematic review of technical considerations and diagnostic accuracy

Ana Cristina Gonçalves, Ana Bela Sarmento‐Ribeiro, Joana Jorge, Bárbara Oliveiros et al.
Figshare
Extracellular vesicles in disease
article

Diagnostic value of tumor-educated platelet transcriptomics in cancer: a systematic review of technical considerations and diagnostic accuracy

Ana Cristina Gonçalves, Ana Bela Sarmento‐Ribeiro, Joana Jorge, Bárbara Oliveiros, João Bernardo Colaço, Raquel Alves
article en

Abstract

Cancer remains a leading cause of morbidity and mortality worldwide, and the search for noninvasive markers for cancer screening and diagnosis, as well as for patient monitoring, is of utmost importance to better and earlier detect cancer. As the second most abundant cell type in the bloodstream, platelets interact bidirectionally with cancer cells, acquiring cancer-associated molecular alterations that modify their transcriptomic profile and give rise to so-called tumor-educated platelets (TEPs). As an easily accessible and abundant blood component, TEPs have emerged as a promising liquid biopsy source for cancer diagnostic biomarkers. This systematic review aimed to evaluate the clinical utility of the TEP transcriptome as a potential source of diagnostic biomarkers in solid and hematological neoplasias. It also identifies the major challenges and future perspectives for their clinical implementation. The review protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO: CRD42024486960).

Figshare
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon